For many years, C-peptide testing was viewed as a simple tool to distinguish type 1 diabetes from type 2 diabetes. However, the story has changed. As researchers gain a better understanding of pancreatic beta-cell function, C-peptide testing in diabetes has become much more valuable than a diagnostic aid alone. Today, …
Read More »Misdiagnosed as Type 2? Why We Need to Screen More Adults for LADA
Up to 10% of adults diagnosed with type 2 diabetes may actually have Latent Autoimmune Diabetes in Adults (LADA), yet many cases remain undetected for years. Because symptoms often develop slowly, LADA is frequently mistaken for traditional type 2 diabetes. However, the wrong diagnosis can delay insulin therapy, worsen glucose …
Read More »The Diabetes Diagnosis Gap: Are We Missing Patients Who Don’t Fit Classic Risk Profiles?
Diabetes screening has improved over the last two decades, yet many patients still fall through the cracks. While clinicians often rely on traditional risk models that focus on obesity, age, family history, and sedentary lifestyle, not every patient with diabetes fits that familiar picture. As a result, many diabetes cases …
Read More »Diabetes Without Clear Etiology: When Patients Don’t Fit Type 1 or Type 2
What happens when a patient walks into your clinic and their diabetes simply doesn’t fit the usual mold? In many cases, clinicians rely on well-established categories like Type 1 or Type 2 diabetes. However, diagnosing atypical forms of diabetes is becoming increasingly important as more patients present with mixed or …
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.